Enhancing Adherence and Knowledge of Erlotinib in Patients Wtih Non-Small Cell Lung Cancer
Clinical trial NCT01378598 · COMPLETED
Trial details
- NCT number
- NCT01378598
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-02-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.